 Anew Clinical Derma-Full X3 Facial Filling Serum - First to market product
- Serum containing same quality injectable grade Hyaluronic Acid as used by dermatologists
- Launches: April 2009
- 30ml, €44.75
Avon's Anew Clinical Derma-Full X3 Facial Filling Serum is a first to market innovation in anti-ageing skincare. This potent anti-ageing serum contains the exact same quality injectable-grade Hyaluronic Acid facial filler used by dermatologists. Experience dramatic facial filling results in the privacy of your home for a fraction of the cost of a dermatological treatment as this revolutionary new product successfully delivers a purer form of Hyaluronic Acid, a key natural component of healthy skin and a proven wrinkle filler. Avon uses breakthrough technology to stimulate the skin's own filling fibres and help build the skin's natural reserve of Hyaluronic Acid. Helping provide visible volume restoration in the skin, giving you the youthful results you've always wanted with no needles in sight. "Every woman wants to look younger and many people pay hundreds for filling injections. It is remarkable that Avon is now able to provide injectable grade filler in a topical serum at an accessible price," states Dr. Cheryl Karcher, certified dermatologist based in New York. Avon's beauty expert, Nicky Hambleton-Jones comments: "We all notice when the skin on our face starts to sag. Now you can plump up your face without leaving the house with this remarkable product. It's a miracle in a bottle." Avon was the first mass beauty company to use AHAs (alpha hydroxy acids, known as ‘fruit acid') in skincare products, which is now an industry standard for clearer, more vibrant skin. Avon was also the first to stabilise retinol for use in anti-ageing treatments and the first online cosmetics retailer (1997), setting the trend for other beauty brands. With yet another first to market it is no wonder that Avon is and continues to be at the forefront of skincare innovation. Smooth Anew Clinical Derma-Full X3 Facial Filling Serum over cleansed face and neck nightly and the results are remarkable:youthful facial fullness is restored as the look of deep facial folds dramatically reduces over time. Proven results noticeable in weeks*: - In two weeks, 82% of women saw more youthful fullness in the cheek area **
- After four weeks, the look of facial folds and hollowness is dramatically reduced**
- Over time, recreates youthful contours and adds definition to the face, jaw line and neck areas as it help reduce the look of deep folds**
Since 2003 Avon has been developing Anew Clinical products for women who want to stay a step ahead of the ageing process and are committed to doing whatever it takes to look their youthful best, short of going to the dermatologist. *Results not comparable to professional procedures **Based on those who expressed an opinion in a consumer perception study First to market claim - Correct at time of market analysis 15/01/09, source: ESA Report No 47229 Avon's Anew Clinical Derma-Full X3 Facial Filling Serum is €44.75. Avon products are available from a network of independent Avon sales representatives all over the country. To find your nearest one or to see a brochure please call 01 870 6540 or visit www.avon.ie - Avon products are backed by a 100 per cent money-back guarantee. Images available on request.
- Avon Ireland, which celebrates its 15th anniversary this year, is part of a global corporation with annual turnover in excess of $10 billion, the largest beauty company in the world selling direct to women. Avon operates in over 120 countries through a network of 5.5 million independent sales Representatives.
- Avon product lines include well-known brands including Avon Colour, ANEW, Skin So Soft, Advance Techniques hair care and designer fragrances such as Christian Lacroix and U by Ungaro. Avon also sells an extensive range of wellbeing products, lingerie, jewellery, accessories and gifts. Actress Reese Witherspoon is Avon's global ambassador and honorary chairman of the Avon Foundation.
- The Avon Breast Cancer Crusade in Ireland has raised E800,000 (1998 - 2008) in association with long-term charity partner ARC Cancer Support. Globally the Crusade has raised over $600 million since 1992 in 50 countries.
|